Skip to main content
Fig. 3 | Arthritis Research & Therapy

Fig. 3

From: Calgizzarin (S100A11): a novel inflammatory mediator associated with disease activity of rheumatoid arthritis

Fig. 3

S100A11 in serum and synovial fluid and its association with disease activity in rheumatoid arthritis (RA). Levels of S100A11 in the synovial fluid (a) but not in the serum (b) were up-regulated in patients with RA compared to patients with osteoarthritis (OA) when adjusted for age and sex. Levels of S100A11 in synovial fluid correlated with serum C-reactive protein (CRP) (c), disease activity score in 28 joints (DAS28) (d), synovial fluid leukocyte count (e), serum anti-cyclic citrullinated peptide antibodies (anti-CCP) (f), IL-6 (g) and IL-8 (h). The horizontal line represents the median

Back to article page

Arthritis Research & Therapy

ISSN: 1478-6362

Contact us